EcoDrugPlus

Ensembl ID : ENSODEG00000009267
Gene Symbol: -
Cross references: -
232 Possible Orthologues:

Ensembl ID : ENSODEG00000014905
Gene Symbol: -
Cross references: -
140 Possible Orthologues:

Ensembl ID : ENSODEG00000019117
Gene Symbol: -
Cross references: -
200 Possible Orthologues:

Ensembl ID : ENSODEG00000008032
Gene Symbol: -
Cross references: -
239 Possible Orthologues:

Ensembl ID : ENSODEG00000017912
Gene Symbol: -
Cross references: -
217 Possible Orthologues:

Ensembl ID : ENSODEG00000016904
Gene Symbol: -
Cross references: -
253 Possible Orthologues:

Ensembl ID : ENSODEG00000019422
Gene Symbol: -
Cross references: -
130 Possible Orthologues:

Ensembl ID : ENSODEG00000019300
Gene Symbol: -
Cross references: -
150 Possible Orthologues:

Ensembl ID : ENSODEG00000019686
Gene Symbol: -
Cross references: -
229 Possible Orthologues:

Ensembl ID : ENSODEG00000019987
Gene Symbol: -
Cross references: -
239 Possible Orthologues:

Ensembl ID : ENSODEG00000020147
Gene Symbol: -
Cross references: -
131 Possible Orthologues:

Ensembl ID : ENSODEG00000014382
Gene Symbol: -
Cross references: -
93 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).